← SynDRA
DU-728
SynDRA canonical compound SYN0087405 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ITGB3 |
|---|
| Mechanism of action | Structural glycoprotein antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Structural glycoprotein antagonist
Cross-references
Synonyms
- Arg-gly-asp-ser
- Rgds peptide
- Fibronectin tetrapeptide
- Arginyl-glycyl-aspartyl-serine
- AC6UDA2MFC
- L-Serine, L-arginylglycyl-L-alpha-aspartyl-
- RefChem:113929
- RGDS
- H-Arg-Gly-Asp-Ser-OH
- MFCD00076452
- C15H27N7O8
- L-Arginylglycyl-L-alpha-aspartyl-L-serine
- UNII-AC6UDA2MFC
- RGDS peptide; Fibronectin tetrapeptide
- Arg-Gly-Asp-Ser?
- Arg-Gly-Asp-Ser peptide
- orb363878
- orb2815842
- SCHEMBL7394659
- L-Serine, N-(N-(N-L-arginylglycyl)-L-alpha-aspartyl)-
- SCHEMBL29350833
- Fibronectin Inhibitor Tetrapeptide
- CHEBI:232857
- NNRFRJQMBSBXGO-CIUDSAMLSA-N
- BDBM50241180
- RGDS peptide;Fibronectin tetrapeptide
- AKOS024457642
- Arg-Gly-Asp-Ser, >=95% (HPLC)
- CS-3266
- FR73590
- NCGC00167153-01
- AS-56630
- DA-61200
- HY-12290
- R2513
- C77102
- T10366
- BRD-K08859203-001-01-9
- L-SERINE, L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-
Look up DU-728 in the interactive SynDRA portal →